Form 8-K - Current report:
SEC Accession No. 0001193125-19-201312
Filing Date
2019-07-24
Accepted
2019-07-24 16:48:55
Documents
5
Period of Report
2019-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 4.01: Changes in Registrant's Certifying Accountant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d771569d8k.htm 8-K 26274
2 EX-2.1 d771569dex21.htm EX-2.1 102005
3 EX-16.1 d771569dex161.htm EX-16.1 1652
4 EX-99.1 d771569dex991.htm EX-99.1 10155
5 GRAPHIC g771569g36x56.jpg GRAPHIC 7705
  Complete submission text file 0001193125-19-201312.txt   152260
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 19971526
SIC: 2834 Pharmaceutical Preparations